Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Assets
Unrestricted cash and cash equivalents	$ 60,968	$ 41,484
Restricted cash and cash equivalents	80,786	29,174
Loans, interest and fees receivable:
Loans, interest and fees receivable, at fair value	6,306	11,109
Loans, interest and fees receivable, gross	541,344	393,898
Allowances for uncollectible loans, interest and fees receivable	(79,211)	(62,970)
Deferred revenue	(43,897)	(36,956)
Net loans, interest and fees receivable	424,542	305,081
Property at cost, net of depreciation	3,625	3,229
Investments in equity-method investees	2,476	4,244
Deposits	124	252
Prepaid expenses and other assets	10,087	42,149
Total assets	582,608	425,613
Liabilities
Accounts payable and accrued expenses	105,765	115,737
Notes payable, at face value	390,927	226,238
Notes payable to related parties	40,000	40,000
Notes Payable, at fair value held by VIEs	5,651	9,240
Convertible senior notes	62,142	61,393
Income tax liability	252	9,132
Total liabilities	604,737	461,740
Commitments and contingencies (Note 11)
Equity
Common stock, no par value, 150,000,000 shares authorized: 15,563,574 shares issued and outstanding (including 1,459,233 loaned shares to be returned) at December 31, 2018; and 15,291,884 shares issued and outstanding (including 1,459,233 loaned shares to be returned) at December 31, 2017
Paid-in capital	213,435	212,785
Accumulated other comprehensive income (loss)	3,558	(2,178)
Retained deficit	(238,784)	(246,640)
Total shareholders’ deficit	(21,791)	(36,033)
Noncontrolling interests	(338)	(94)
Total deficit	(22,129)	(36,127)
Total liabilities and deficit	$ 582,608	$ 425,613